SCHEMBL28699718

SCHEMBL28699718

CN1C(=O)Cc2c1cccc2S(=O)(=O)Cl

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRPF1 P55201 1/20 0.36
CCNB2 O95067 1/20 0.35
CDK1 P06493 1/20 0.35
CCNB1 P14635 1/20 0.35
GSK3B P49841 1/20 0.35
CCNB3 Q8WWL7 1/20 0.35
THRB P10828 1/20 0.35
OPRK1 P41145 1/20 0.35
PDE4D Q08499 1/20 0.35
PKM P14618 3/20 0.34
ROCK1 Q13464 1/20 0.33
BRD4 O60885 1/20 0.33
DRD2 P14416 1/20 0.33
LMNA P02545 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
OPRL1 P41146 1/20 0.33
TTR P02766 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL746562 0.76 NOTUM (0.44) BRPF1CCNB2CDK1CCNB1GSK3B
SCHEMBL256751 0.74 KMT2A (0.46) BRPF1CCNB2CDK1CCNB1GSK3B
SCHEMBL15079238 0.73 BRPF1 (0.38) BRPF1CCNB2CDK1CCNB1GSK3B
SCHEMBL26621513 0.73 MEN1 (0.44) BRPF1CCNB2CDK1CCNB1GSK3B
SCHEMBL745354 0.73 GSK3B (0.44) BRPF1CCNB2CDK1CCNB1GSK3B
SCHEMBL24080922 0.73 BRPF1 (0.40) BRPF1CCNB2CDK1CCNB1GSK3B
SCHEMBL5441241 0.73 BRPF1 (0.40) BRPF1CCNB2CDK1CCNB1GSK3B
SCHEMBL3484140 0.73 DRD2 (0.40) BRPF1CCNB2CDK1CCNB1GSK3B
SCHEMBL18069197 0.71 LMNA (0.45) BRPF1CCNB2CDK1CCNB1GSK3B
SCHEMBL13533089 0.70 FAAH (0.42) BRPF1CCNB2CDK1CCNB1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109651208-B N-aryl sulfonamide compound, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2022-01-04 CN disclosed